WT1 and neoplasm: Although it is unclear whether WT1 overexpression is a causal contributor to the carcinogenic state or its consequence, WT1 is undeniably a promising tumor-associated antigen with potentially revolutionary applications, including evaluation of prognosis, detection of minimal residual disease/relapse, and immunotherapy, which are currently under investigation [86,87,88,89].